05.31.2024
03.19.2024
03.05.2024
11.06.2023
09.20.2023
08.07.2023
06.29.2023
January 2017
November 2016
April 2016
October 2015
February 2015
December 2014
October 2014
December 2012
September 2012
November 2011
October 2011
August 2010
June 2010
April 2009
March 2009
December 2008
November 2008
September 2008
June 2008
April 2007
December 2006
July 2006
October 2024
Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study Data for Anaphylm™ (epinephrine) Sublingual Film Evaluating Intraoral Movement at American College of Allergy Asthma and Immunology (ACAAI) 2024 Annual Meeting
In-Person Author Presentation Scheduled for:
Friday, October 25, 2024
Time: 3:45PM (ET)
Presentation Time: 15 minutes
Abstract Title: Sublingual Epinephrine Film's Mucoadhesive Properties Ensures Consistent Oral Placement and Drug Release
Monitor: 16
Exhibit Hall A
ePoster ID: R008
May 2024
Eastern Allergy Conference
May 30 through June 2, 2024
Palm Beach, Florida
Two poster presentations:
Poster Title: Epinephrine Administered via Sublingual Film, Manual Injection, or Auto-Injectors in Healthy Adults: Pharmacodynamic Results
Presentation Time: Friday, May 31, 9:45-11am
Lead Author: Gary Slatko, MD
Poster Title: Pharmacokinetics and Pharmacodynamics of Epinephrine Following Administration via Sublingual Film, Autoinjector, or Manual Injection
Presentation Time: Friday, May 31, 9:45-11am
Lead Author: David Golden, MD
April 2024
Poster Title: Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
Poster Session 9: Epilepsy/Clinical Neurophysiology (EEG): Anti- seizure Medications: Mechanisms, Pharmacokinetics, and Urgent Applications
Location: Denver, CO.
Presentation Time: Wednesday, April 17, from 8:00 AM - 9:00 AM.
Lead author: Gary Slatko, MD, Steve Wargacki, PhD, Michael A. Rogawski, MD, PhD
February 2024
Poster Title: Pharmacokinetics and Pharmacodynamics of Epinephrine Following Administration via Sublingual Film, Autoinjector, or Manual Injection
Poster Session: Therapeutic Trials in Allergic Skin Disorders and Anaphylaxis 2024
Location: Washington D.C.
Lead author: David Golden, MD
Dates: Friday, February 23
Time: 3:15-4:15 PM CT
Posters: Pharmacokinetics and Pharmacodynamics of Epinephrine Following Administration via Sublingual Film, Autoinjector, or Manual Injection
Poster Number: 034
November 2023
Location: ePoster Section - Exhibit Hall
Monitor: 11
Dates:Friday, November 10th
Time: 3:45 - 4:00 PM (PT)
Posters:
Abstract ID: 8053
ePoster ID: P004
Presentation Time: Friday, November 10th 3:45 - 4:00 PM (PT)
Location: ePoster Section - Exhibit Hall
Monitor: 11
Date: Friday, November 10th
Posters:
Abstract ID:8052
ePoster ID: P005
Presentation Time:Friday, November 10th 4:00 - 4:15 PM (PT)
February 2023
Location: San Antonio, TX
Dates: February 24-27, 2023
Posters:
EPIPHAST Part 3 AAAAI 2023 Oppenheimer final
Poster Title: IMPACT OF FOOD EXPOSURE ON THE PHARMACOKINETICS OF EPINEPHRINE SUBLINGUAL FILM
Poster Number: 7
Presentation Time: Friday February 24th 3:15-4:15 PM
Lead Author: John Oppenheimer, M.D., UMDNJ Rutgers University School of Medicine
EPIPHAST Part 3 AAAAI 2023 Bernstein final
Poster Title: PHARMACOKINETICS OF EPINEPHRINE SUBLINGUAL FILM FOLLOWING THREE DIFFERENT ADMINISTRATION PROCEDURES
Poster Number: 17
Presentation Time: Friday February 24th 3:15-4:15 PM
Lead Author: David Bernstein M.D., University of Cincinnati College of Medicine
EPIPHAST Part 2 AAAAI 2023 Golden final
Poster Title: PHARMACOKINETICS AND PHARMACODYNAMICS OF EPINEPHRINE SUBLINGUAL FILM VERSUS INTRA-MUSCULAR EPINEPHRINE
Poster Number: 12
Presentation Time: Friday February 24th 3:15-4:15 PM
Lead Author: David Golden M.D., Medstar Franklin Square Hospital
EPIPHAST II AAAAI 2023 Greenhawt final
Poster Title: COMPARISON OF THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILES OF EPINEPHRINE DELIVERED BY A SUBLINGUALLY ABSORBED FILM VERSUS 0.3 MG ADMINISTERED BY A STANDARD IM INJECTION OR THE EPIPEN®
Poster Number: L13
Presentation Time: Friday February 24th 3:15-4:15 PM
Lead Author: Matthew Greenhawt, M.D., MBA, MSc, Children's Hospital Colorado
November 2022
Location: Virtual
Dates: November 30-December 1
Available for investor meetings on Thursday, December 1st
Location: New York, NY
Dates: November 29-December 1
Presentation: Wednesday, November 30th at 1:50 pm ET
Location: Louisville, KY
Dates: November 10-14
Poster Details:
Abstract Title: Pharmacokinetics Study of Epinephrine Sublingual Film: Results from The Formulation and Dosage Selection
Presenting Author: Dr. John Oppenheimer, MD (UMDNJ Rutgers University School of Medicine)
Abstract Title: Minimal Impact of Food, Drink, Or Temperature on The Pharmacokinetics of a Sublingual Film Using a Novel Prodrug of Epinephrine (DESF)
Presenting Author: Holly Ponichtera, PhD (Aquestive Therapeutics)
Abstract Title: Results of a Repeat Dose Study on The Pharmacokinetics of a Sublingual Film using a Novel Prodrug of Epinephrine (DESF)
Presenting Author: Holly Ponichtera, PhD (Aquestive Therapeutics)
February 2022
Location: Phoenix, AZ
Dates: February 25-28
Poster: (L37) A Phase 1, Randomized Study Evaluating the Safety Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single Ascending Doses of Epinephrine Prodrug 109 Sublingual Film (AQST-109) in Healthy Male Volunteers
December 2019
Location: Baltimore, MD
Dates: December 6 - December 10, 2019
Booths: #344 and #547
October 2019
Location: Charlotte, NC
Dates: October 23 - October 26, 2019
Booths: #820 and #821
November 2018
Location: New Orleans, LA
Dates: November 30 - December 4, 2018
Location: Boca Raton, FL
Dates: November 1-4, 2018
October 2018
Location: Chicago, IL
Dates: October 15-18, 2018
September 2018
Location: San Francisco, CA
Dates: September 10-11, 2018
Location: Boston, MA
Dates: September 5-6, 2018
June 2018
Location: Boston, MA
Dates: June 4-7, 2018
April 2018
Location: Los Angeles, CA
Dates: April 21-27, 2018
March 2018
Location: San Diego, CA
Dates: March 17-20, 2018
Location: Rockville, MD
Dates: March 7-10, 2018
February 2018
Location: San Francisco, CA
Dates: February 22-23, 2018
January 2018
Location: Palm Beach Gardens, FL
Dates: January 22-24, 2018
Mark Schobel, Chief Innovation & Technology Officer, participated in a panel discussion titled “Oral Thin Films from Development to Commercialization”
Location: San Francisco, CA
Dates: January 8-10, 2018
Location: San Francisco, CA
Dates: January 8-11, 2018
December 2017
Location: Boston, MA
Dates: December 8-10, 2017
Location: Washington, D.C.
Dates: December 1-5, 2017
October 2017
Location: Laguna Niguel, CA
Dates: October 23–25, 2017
Location: Boston, MA
Dates: October 19–20, 2017
September 2017
Location: Boston, MA
Dates: September 26–27, 2017
August 2017
Location: Boston, MA
Dates: August 28–29, 2017
December 2021
December 2019
November 2018
April 2018
March 2018